Coldstream Capital Management’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,437
Closed -$166K – 1868
2025
Q1
$166K Sell
2,437
-811
-25% -$55.7K ﹤0.01% 1096
2024
Q4
$212K Buy
3,248
+8
+0.2% +$556 ﹤0.01% 984
2024
Q3
$236K Buy
3,240
+6
+0.2% +$429 0.01% 964
2024
Q2
$222K Buy
3,234
+7
+0.2% +$473 0.01% 899
2024
Q1
$225K Buy
3,227
+6
+0.2% +$406 0.01% 893
2023
Q4
$208K Buy
+3,221
New +$197K 0.01% 882
2023
Q2
– Sell
-4,809
Closed -$296K – 835
2023
Q1
$296K Sell
4,809
-3,193
-40% -$198K 0.01% 635
2022
Q4
$512K Buy
+8,002
New +$500K 0.02% 421
2022
Q2
$506K Buy
8,338
+5,163
+163% +$320K 0.02% 386
2022
Q1
$208K Buy
3,175
+7
+0.2% +$446 0.01% 739
2021
Q4
$218K Buy
+3,168
New +$208K 0.01% 763
2021
Q3
– Sell
-3,157
Closed -$201K – 457
2021
Q2
$201K Buy
+3,157
New +$194K 0.01% 517

Other funds holding FHLC

Coldstream Capital Management's FHLC Position: Q2 2025 in Review

Coldstream Capital Management sold out of Fidelity MSCI Health Care Index ETF (FHLC) in Q2 2025, closing a stake of 2,437 shares — an estimated $166K sold.

Coldstream Capital Management first reported a position in FHLC in Q2 2021 and held it in 12 quarters. The position peaked at $512K in Q4 2022. 337 funds tracked by Wall St. Rank hold FHLC as of Q2 2025.

  • Coldstream Capital Management reported no remaining Fidelity MSCI Health Care Index ETF position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 2,437 Fidelity MSCI Health Care Index ETF shares in Q2 2025, an estimated $166K.
  • Coldstream Capital Management first reported a position in Fidelity MSCI Health Care Index ETF in Q2 2021 and held it in 12 quarters.
  • Coldstream Capital Management's Fidelity MSCI Health Care Index ETF position peaked at $512K in Q4 2022.
  • 337 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.